Rybelsus 14 mg, Tabletten
7680674460077
CH-67446
Tabletten
Associated product:
RYBELSUS cpr 14 mg 30 pce
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
semaglutidum
|
14.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii salcaprozas
|
- | Substance | HNIDK |
|
natrium
|
22.9 MG | Substance | HBESI |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
povidonum K 90
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
Authorization holder
Novo Nordisk Pharma AG
8302 Kloten
Authorization information
- Swissmedic authorization number
- 67446
- Drug name
- Rybelsus, Tabletten
- Galenic form
- TAB
- ATC Code
- A10BJ06
- Authorization status
- Revoked/Withdrawn
- Dispensing category
- B
- First authorization
- 24/03/2020
- Authorization expiration date
- 30/08/2026
- IT Number
- 07.06.2.
- Domain
- Human medicine
Package details
- Description (FR)
- RYBELSUS cpr 14 mg 30 pce
- Description (DE)
- RYBELSUS Tabl 14 mg 30 Stk
- Market launch
- 24/03/2020
- Market withdrawal
- 30/08/2026
- Narcotic (BTM)
- No